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ABSTRACT 
 
INTRODUCTION: Acute infusion reactions from antineoplastic agents can include 
hypersensitivity reactions, anaphylaxis, and cytokine release infusion reactions. Severe acute 
infusion reactions happen in about 5% of the oncology patient population and nurses are 
responsible for assessment and management of the reaction. This is a high stress task for a nurse 
magnified by the lack of exposure. This project explores nursing knowledge and perceived 
comfort level of acute infusion reactions caused by antineoplastic agents.  
METHODOLOGY: An original survey was created to test nursing knowledge and assess 
comfort level. Nursing knowledge was broken down into six subscales: general knowledge of 
acute infusion reactions, signs and symptoms of hypersensitivity, anaphylaxis, and cytokine 
release infusion reaction, and drugs most likely to cause hypersensitivity and anaphylactic 
reactions and cytokine release infusion reactions. Comfort questions were asked on a 6-point 
Likert scale from extremely uncomfortable to extremely comfortable. There was an additional 
section in the survey related to nurses’ distress and support in situations with acute infusion 
reactions. The questions were presented using a 6-point Likert scale ranging from strongly 
disagree to strongly agree. There were two open-ended questions that were designed to allow the 
nurses to share any additional information about their experiences with acute infusion reactions.  
Oncology nurses working with adults and pediatric populations were invited to participate. 
Descriptive statistics were used to analyze the survey results.  T tests were used to compare 
groups and Pearson R statistics were used to examine relationships between total knowledge, 
knowledge subscale score, and comfort level.  
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RESULTS: 20 nurses completed the survey. 12 were from the adult nurse population and 8 were 
from the pediatric nurse population. The typical participant was forty-four years of age, had 
sixteen years experience as a Registered Nurse, and thirteen years experience in the oncology 
setting. The average total knowledge score was a 56% based on 84 possible points. The basic 
knowledge section and the anaphylactic signs and symptoms were the highest scoring subscales, 
both scoring a 62%. Cytokine release infusion reaction signs and symptoms was the lowest 
scoring subscale with a 45%.  There were no significant differences in knowledge between 
groups. The nurses chose an overwhelming agree/strongly agree when asked to choose the signs 
and symptoms related to each type of infusion reaction. The total comfort level score indicated 
that nurses were very comfortable managing acute reactions. There was no significant difference 
between the adult and pediatric setting comfort level scores.  There was no statistically 
significant relationship between total knowledge score and total comfort level score.  
DISCUSSION: The knowledge score showed knowledge deficits while the comfort score 
indicated confidence in management of acute infusion reactions. The high frequency of 
agree/strongly agree for all three subscales of signs and symptoms indicates that the nurses at 
least know what to look for even if they cannot assign the specific sign and symptom to the type 
of infusion reaction. Knowledge about signs of specific types of drug reactions may not be 
necessary as long as a basic understanding of what to look for and how to manage a reaction is 
present.  
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INTRODUCTION 
 
According to The American Cancer Society, in 2015 there was an estimated 1,658,370 
newly diagnosed cases of cancer in the United States (2015). For a majority of these patients the 
best course of action for treating cancer is the use of chemotherapy or biotherapy. These drugs 
help patients in the treatment of their disease, but sometimes these antineoplastic drugs can cause 
an acute infusion reaction (Lee, Gianos, & Klaustermeyer, 2009).  
The acute infusion reaction can be categorized as a hypersensitivity reaction or an 
anaphylactic reaction (to chemotherapy), or a cytokine release infusion reaction (to biotherapy). 
The hypersensitivity reaction can range from minor skin rashes and pruritus to nausea and 
vomiting. The anaphylactic reaction can cause hemodynamic instability i.e. bronchoconstriction 
and eventually lead to shock (Gobel & O’Leary, 2011). The cytokine immune response typically 
happens with the first infusion of the immunotherapy drug and can exhibit all of the symptoms of 
a hypersensitivity reaction (Gobel & O’Leary, 2011).  
The overall rate of severe hypersensitivity reactions, or those that could lead to 
anaphylaxis, in antineoplastic drugs is about five percent (Gabel &O’Leary, 2011). While this is 
rare, anaphylaxis can be severe enough to lead to death, and quick recognition and response by 
nurses is crucial to patient survival.  
For some antineoplastic drugs, skin testing can be done to determine a patient’s 
likelihood of a hypersensitive reaction (Lee, Gianos, & Klaustermeyer, 2009). Certain drugs can 
be given with a desensitizing agent, and other drugs can be given at a slower IV infusion rate 
(Gobel & O’Leary, 2011). However, acute infusion reactions are not 100% preventable, and the 
antineoplastic drug may be the only treatment option available to treat the disease.  Furthermore, 
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a hypersensitivity reaction can occur at any time during an infusion. Just because a patient did 
not show any signs of a reaction during the first or second infusion does not mean that a reaction 
will not take place on a subsequent dose (Gabel &O’Leary, 2011 & Maloney, 2016).  
The nurse’s role is to educate the patient and family on the signs and symptoms of acute 
infusion reactions, follow correct procedures for giving the antineoplastic treatment, monitor the 
patient against expected norms and baseline vital signs, and respond appropriately to 
hypersensitivity and anaphylactic reactions (Maloney, 2016). The nurse’s role is vital in the 
treatment of anaphylaxis, which could lead to death if not treated quickly and correctly.  
This creates a high stress environment for the nurse. If a reaction occurs, nurses not only have to 
be comfortable in responding quickly, they need to be confident enough to calm and reassure the 
patient. The patient can experience a great deal of fear and anxiety related to the treatment plan. 
The nurse needs to be equipped with the confidence to reassure the patient in his/her ability to 
recognize and respond quickly to potential reactions.  
Oncology nurses are expected to give complex chemotherapeutic drug regimens while 
ensuring the patient’s other healthcare needs are addressed. The high demands placed on 
oncology nurses to complete complex tasks and deal with emotionally draining patients has been 
known to cause burnout (Russel, 2016). The demanding schedule of oncology nurses may 
greatly impact their stress levels when encountering a patient who is having a hypersensitivity 
reaction to chemotherapy or a cytokine release infusion reaction to biotherapy.  
Currently there are no studies about nurses’ knowledge level and perception of comfort 
level to treat and respond to acute infusion reactions caused by antineoplastic agents. With the 
infrequency of this severe reaction, nurses may not feel comfortable with their knowledge and 
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ability to manage the reaction. The goal of this research will be to explore if the nurses’ 
knowledge of acute infusion reactions relates to their perceived comfort level in dealing with 
these reactions in the oncology patient.  
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METHODS  
Study Design  
This study used a cross sectional descriptive design. An online survey, developed by the 
principal investigator, was made available to nurses working with oncology patients at the 
University of Florida (UF) Health Cancer Center-Orlando and Arnold Palmer Hospital. The 
research was completed through the University of Central Florida’s Honors in the Major 
program under the supervision of Dr. Victoria Loerzel.  
The primary objective of this research was to evaluate nurses’ knowledge and perceived 
comfort levels related to risk factors, signs and symptoms, and actions towards acute infusion 
reactions from antineoplastic agents in oncology patients.  A secondary objective was to explore 
any relationships between nurses’ knowledge and comfort level towards acute infusion reactions 
from antineoplastic agents.   
Research Aims:  
1) What is the nurse’s basic knowledge level with acute infusion reactions from 
antineoplastic agents? 
2) What is the nurse’s overall comfort level with managing acute infusion reactions from 
antineoplastic agents?  
3) What is the relationship between nurses’ knowledge and comfort level towards acute 
infusion reactions from antineoplastic agents?   
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Sample and Setting 
Participants for this study were registered nurses who worked with the pediatric or adult 
oncology population at Arnold Palmer Hospital or the UF Health Cancer Center – Orlando in 
both the inpatient and outpatient settings. Nurses were included if they were 18 years or older, 
worked directly with oncology patients, and administered antineoplastic agents. Nurses were 
excluded if they were clinic or office nurses who did not administer antineoplastic agents to 
oncology patients. 
Procedure 
Sub-Investigators, Dr. Patricia Geddie and Ms. Jennifer Penn explained the purpose of 
the study to potential participants during “huddles” at UF Cancer Center-Orlando and Arnold 
Palmer Hospital respectively. An e-mail inviting nurses to participate was sent to the nurses’ 
work e-mail accounts and included an informational letter and a link to progress to the survey on 
Qualtrics if they chose to participate. Consent was conveyed if the nurse answered questions on 
the survey. The survey was anonymous and no personal identifiers were collected. All data was 
kept private and confidential.   
The survey was open for two weeks from June 7, 2016 through June 21, 2016. 
Participants were asked to complete a 114 question investigator-developed instrument designed 
to assess nursing knowledge of acute infusion reactions and evaluate nurses’ comfort level in 
managing these acute infusion reactions in the oncology setting.  Demographic questions were 
also included. The survey was expected to take 20 minutes to complete.  
.  
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Instrument  
The Orlando Health Adult Oncology Chemotherapy Hypersensitivity Reaction Protocol 
and the well-known Cancer Nurses Principals and Practice and Core Curriculum for Oncology 
Nursing books were the resources used to create the survey.  Dr. Patricia Geddie, a clinical nurse 
specialist with over 30 years of experience in oncology nursing from the UF Health Cancer 
Center, and Jennifer Penn, a Learning Specialist from Arnold Palmer Hospital for Children, 
agreed to review the survey as experts in the oncology field and provide face validity. They 
provided feedback related to the survey content and relevance to acute infusion reactions.  This 
feedback was used to revise the survey. Qualtrics software was used to design the survey and 
collect data.  
The survey was designed to test nurses’ knowledge of acute infusion reactions and to rate 
their perceived comfort level with managing the reactions. First, a series of demographic 
questions were asked to determine experience, followed by knowledge questions presented in 
multiple choice, true/false, and Likert scale format, and then a Likert scale was used to ask 
questions about comfort level and feelings about the stress and support surrounding the nurses 
when dealing with these reactions. Finally two qualitative questions were asked to assess nurses’ 
desire for further education and to give them a chance to add anything they felt was important. 
All sections are described in more detail below.  
Twelve demographic questions were asked related to participant age, highest degree 
completed, number of years in practice, number of years working with the oncology patient 
population, membership in professional organizations, experience giving antineoplastic drugs, 
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additional training completed, current work setting, the primary patient population, and the 
frequency the nurse encounters acute infusion reactions from antineoplastic agents.   
Knowledge questions were broken down into six subscales: the basic knowledge subscale 
(n=17), signs and symptoms of hypersensitivity reactions (n=15), signs and symptoms of 
anaphylactic reactions (n=15), signs and symptoms of cytokine release infusion reactions (n=15), 
drugs that have a high potential to cause hypersensitivity and anaphylaxis (n=11), and drugs that 
have a high potential to cause cytokine release infusion reactions (n=11). A total knowledge 
score was computed based on the number of correct answers for all of these items with the 
highest possible score being 84 points. 
The basic knowledge subscale had 4 multiple choice questions, 12 true/false questions, 
and 1 select all that apply. These questions were related to type and frequency of acute infusion 
reactions, factors that increase the risk of acute infusion reactions, and protocol for assessing and 
managing an acute infusion reaction.  
The sign and symptom subscales were created using a 5-point Likert scale that ranged 
from strongly disagree to strongly agree. Participants were awarded points for choosing either 
“disagree” or “strongly disagree” for signs and symptoms that were not common to the type of 
acute infusion reaction or for choosing “agree” or “strongly agree” for signs and symptoms that 
were common. No points were awarded for “I don’t know” answers.  
The drugs most likely to cause a reaction subscales were created using the same 5- point 
Likert scale as with the sign and symptoms subscales that ranged from strongly disagree to 
strongly agree. Points were awarded the same way as well.   
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The comfort level questions (n=7) asked nurses to rate their comfort with nursing actions 
related to acute infusion reactions in the oncology setting on a 6- point Likert scale ranging from 
extremely uncomfortable to extremely comfortable. The lowest points possible per question was 
1 for extremely uncomfortable and the highest points possible per question was 6 for extremely 
comfortable choices. The highest total comfort level score possible was 42 points. 
There was an additional section in the survey (n=9) related to nurses’ distress and support 
in situations with acute infusion reactions. The questions were presented using a 6- point Likert 
scale ranging from strongly disagree (1) to strongly agree (6).  
There were two open-ended questions that were designed to allow the nurses to share any 
additional information about their experiences with acute infusion reactions. The first open-
ended question invited the nurse to explain what type of further training he/she would like in the 
future, if any, with acute infusion reactions from antineoplastic agents. The second open-ended 
question was a chance for the nurse to add anything else he/she would like to include about 
his/her experience with acute infusion reactions.   
Data Analysis  
Data was downloaded from Qualtrics into an Excel Spreadsheet and uploaded into SPSS 
version 22 for analysis. This study was analyzed using descriptive statistics (means, frequencies, 
percent’s).  Total knowledge and subscale knowledge scores were computed and aggregated.  T-
tests and ANOVA were used to examine differences between group means (adult and pediatric 
nurses).  Pearson’s R correlations were used to examine relationships between study variables 
(demographic and groups) and knowledge and comfort scores.  
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RESULTS 
  
 Thirty-two nurses accessed the survey, and twenty completed the entire survey. A Chi 
Square test was conducted and revealed that there were no significant demographic differences 
between the nurses who completed the survey versus those who did not. Of those who completed 
the survey, the typical participant was forty-four years of age, had sixteen year’s experience as a 
Registered Nurse, and thirteen year’s experience in the oncology setting. 70% of participants had 
a Bachelor’s Degree, all participants held an additional certification, and were a member of a 
professional nursing oncology organization. Of the twenty participants who completed the 
survey, twelve worked in the adult oncology setting and eight worked in the pediatric oncology 
setting. In the adult oncology setting, seven nurses worked with the inpatient population and five 
worked with the outpatient population. In the pediatric oncology setting six worked in the 
inpatient oncology setting and only two worked in the outpatient oncology setting. See Table 1 
for the demographic characteristics of the whole sample and nurses within the adult and pediatric 
settings  
 
 
 
 
 
 
 
 
 
 
 
 
 10 
___________________________________________________________________________ 
Table 1: Sample Characteristics 
     Whole Group  Adults   Pediatrics  
     (N=20)   (N=12)   (N=8) 
Characteristic    
 Age (χ)     44   45  46 
Degree 
 Diploma     1   1  0 
 Associates    4   3  1 
 Bachelors     14   8  6 
 Masters      1   0  1 
Certifications 
 OCN     8   8  0 
 CPHON     2   0  2 
 CPON     2   0  2 
 ONS Chemotherapy Course  0   0  0 
 APHON Chemotherapy Course  4   0  4 
 OH Verification Course   3   3  0 
 Other      1   1  0 
Member of Professional Organizations   
 APHON     6   0  6 
 ONS     10   10  0 
 Other     4   2  2 
Years as a R.N. (χ)    16   16  18 
Years in oncology (χ)    13   13  13 
Years giving chemotherapy (χ)    13   13  14 
Work setting 
 Inpatient     13   7  6 
 Outpatient    7   5  2 
 Adult     12   0  12 
 Pediatric     8   8  0 
Number of reactions seen in 1 month (χ)   2.4   2.83  1.75 
Number of reactions seen in 1 year (χ)  4.5   4.92  3.88 
_____________________________________________________________________________________________ 
Note Numbers rounded to the nearest whole number.  
(χ) = Sample mean  
 
 
Research Question 1: What is the nurse’s basic knowledge level with acute infusion reactions 
from antineoplastic agents?  
  The mean total knowledge score for all participants of the survey was 47.3 out of 84 
possible points or 56%. Nurses working in the adult oncology setting scored an average of 49.92 
out of 84 possible points or 59%, and nurses working in the pediatric oncology setting scored an 
average of 43.38 out of 84 possible points or 52%.  
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 Table 2 shows a breakdown of the subscale scores for the whole group. The highest 
scores were in the basic knowledge subscale and in recognizing signs and symptoms of an 
anaphylactic reaction. The lowest scores were in recognizing signs and symptoms of both 
hypersensitivity reactions and cytokine release infusion reactions.  
Table 2: Mean Total Knowledge and Subscale Scores for the Whole Group 
Subscale Points Possible  Mean Score  Mean Percent Score  
Basic Knowledge Score 17 10.6 62% 
Hypersensitivity 
Reactions Signs and 
Symptoms  
15 7.45 50% 
Anaphylactic Reactions 
Signs and Symptoms 
15 9.3 62% 
Cytokine Release Infusion 
Reactions Signs and 
Symptoms  
15 6.75 45% 
Drugs that cause 
Hypersensitivity and 
Anaphylactic Reactions  
11 6.7 60% 
Drugs that cause Cytokine 
Release Infusion 
Reactions  
11 6.5 59% 
  
Table 3 shows a breakdown of subscale scores by adult and pediatric settings. In the adult 
setting the highest score (67%) was in the subscale about which drugs are most likely to cause 
cytokine release infusion reaction, followed closely by recognizing signs and symptoms of 
anaphylactic reactions at 65%. Their lowest scores were in recognizing the signs and symptoms 
of hypersensitivity reactions and cytokine release infusion reactions at 51% and 50% 
respectively.  
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In the pediatric setting nurses tended to score slightly lower than nurses in the adult 
setting in all subscales. Their highest score was in the basic knowledge subscale at 62%. Their 
lowest score (38%) was in recognizing signs and symptoms of cytokine release infusion 
reactions. This was the lowest score for nurses in both settings. 
When comparing the two settings further, the biggest gap in subscale scores was in 
recognizing signs and symptoms of cytokine release infusion reactions and selecting drugs most 
likely to cause cytokine infusion reactions. In the adult setting there was a mean score of 50% for 
recognizing the signs and symptoms compared to 38% in the pediatric setting. Likewise in 
selecting drugs the mean was 67% for the adult setting and 48% for the pediatric setting. 
However, this was only about a 2-point difference for the mean score in each subscale.  
Table 3: Mean Knowledge Subscales of Nurses in Adult and Pediatric Settings 
  Adult Setting Pediatric Setting 
Subscale Points Possible  Mean Score  Mean Percent  Mean Score  Mean Percent  
Basic Knowledge 
Score 
17 10.67 63% 10.5 62% 
Hypersensitivity 
Reactions Signs 
and Symptoms 
15 7.67 51% 7.13 48% 
Anaphylactic 
Reactions Signs 
and Symptoms 
15 9.75 65% 8.63 58% 
Cytokine Release 
Infusion Reactions 
Signs and 
Symptoms 
15 7.50 50% 5.63 38% 
Drugs that cause 
Hypersensitivity 
and Anaphylactic 
Reactions 
11 7 64% 6.25 59% 
Drugs that cause 
Cytokine Release 
Infusion Reactions 
11 7.33 67% 5.25 48% 
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In the general knowledge subscale there were some knowledge deficits about the risks 
associated with acute infusion reactions. For example, 75% of participants chose the incorrect 
answer for a question about being able to continue a chemotherapy infusion as long as signs and 
symptoms of hypersensitivity are mild. This is false. The hospitals protocol requires that the 
infusion be stopped immediately at any sign of a reaction. In another example, 60% believed that 
a patient could not receive an antineoplastic drug once he/she has had a reaction. The correct 
answer was false, because there often is not another class of drugs that can be used for treatment. 
Finally 60% of nurses did not know that a patient with a history of hypersensitivity reactions to 
something like food or bee stings is more likely to react to a chemotherapy drug. Prior 
hypersensitivity or allergic reactions are a warning sign that an acute infusion reaction may 
occur. 
Overall, the biggest knowledge deficit was in determining the correct signs and 
symptoms of each specific type of infusion reaction. There was a trend to choose agree or 
strongly agree for most signs and symptoms regardless of the type of infusion reaction. Almost 
every sign and symptom for each of the three infusion reactions had a higher frequency for agree 
and strongly agree. Table 4 outlines the percent of participants who chose agree and strongly 
agree based on the frequencies. There were only seven instances in which the percent of those 
who chose agree/strongly agree was less than 50%.  
Reliability statistics were run on the Likert knowledge based questions. The Alpha 
coefficients were as follows: signs and symptoms of hypersensitivity reactions- 0.838, signs and 
symptoms of anaphylactic reactions- 0.829, signs and symptoms of cytokine release infusion 
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reactions- 0.83, drugs most likely to cause a hypersensitivity or anaphylactic reaction- 0.541, 
drugs most likely to cause a cytokine release infusion reaction- 0.863.  
 
Table 4: Percent of nurses who chose "agree"/"strongly agree" for signs and symptoms of specific infusion 
reactions 
 Hypersensitivity 
Reactions 
Anaphylactic Reactions Cytokine Release 
Infusion Reactions 
 Percent Agree/Strongly 
Agree 
Percent Agree/Strongly 
Agree 
Percent Agree/Strongly 
Agree 
Angioedema  60%** 90% 50% 
Pruritus  90%** 60% 70%** 
Nausea and Vomiting  70%-** 45% 60%** 
Laryngeal Edema  75% 100%** 35% 
Fever or Chills  95% 55% 90%** 
Hypotension  85% 80% 65%** 
Dyspnea  90% 90% 80%** 
Watery Nose  80% 55% 45% 
Feelings of Impending 
Doom  
70%** 95%** 45% 
Tongue or Throat 
Swelling  
75% 100%** 45%** 
Wheezing  80%** 80%** 50%** 
Asthenia  35% 35% 50%** 
Tachycardia  90%** 90%** 75%** 
Bronchospasm  80%** 80%** 60% 
Chest Tightness  80%** 80%** 60% 
Note: ** denotes correct answer.   
 
 The second largest knowledge deficit was in selecting the drugs that would most likely 
cause either hypersensitivity and anaphylactic reactions or cytokine release infusion reactions. 
There was a trend with these two subscales to select “I don’t know” as the answer choice. This 
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trend did not exist in any other subscales. Table 5 shows the percent of “I don’t know” answers, 
the highest of which was 60% for the biotherapy drug Azacitidine.  
 
Table 5: Percent of whole group who responded "I don't know" to drug selection subscales 
 Hypersensitivity and Anaphylactic 
Reactions  
 Cytokine Release Infusion 
Reactions 
Drug Name “I don’t know” percentages Drug Name “I don’t know” percentages 
Procarbazine 45% Interferons 10% 
Methotrexate  5% Interluekons 10% 
Docetaxel 15% Rituximab 5% 
Taxanes  25% Cetuximab 10% 
Hydroxyurea  25% Bortezomib 20% 
Dacarbazine  40% Azacitidine 60% 
Asparaginase  10% Alemtuzumab 45% 
Cisplatin  10% Bevacizumab 25% 
Etoposide  0% Gemtuzumab 25% 
Bleomycin 5% Trastuzumab 25% 
Carboplatin  5% Panitumumab 25% 
 
Research Question 2: What is the nurse’s overall comfort level with managing acute infusion 
reactions from antineoplastic agents?   
 The overall comfort score was a 37.75 out of 42 possible points. All participants were 
moderately to extremely comfortable in most areas.  The overall comfort score for nurses 
working with an adult oncology population was 38.08 out of 42 possible points, and the overall 
comfort score for nurses working with a pediatric oncology population was 37.25 out of 42 
possible points. There was no significant difference in comfort scores between the adult and 
pediatric populations. 10% of the overall population felt slightly uncomfortable about managing 
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an anaphylactic reaction. In addition, 5% of the overall population felt slightly uncomfortable 
administering medications in the event of an anaphylactic reaction.  
Research Question 3: What is the relationship between nurses’ knowledge and comfort level 
towards acute infusion reactions from antineoplastic agents?    
 There was no correlation between total knowledge score and total comfort level score. 
Additionally, correlations were examined between the demographic variables, total knowledge 
and comfort scores. There was no correlation between total knowledge or comfort score and 
nurses who worked in inpatient or outpatient settings. Likewise, there was no correlation 
between total knowledge or comfort score and highest degree achieved or number of years of 
experience. Finally there was no correlation between the total knowledge or comfort score and 
number of acute infusion reactions seen in a month or year. Positive correlations were noted 
between several of the knowledge subscales (Cytokine Release Infusion Reaction signs and 
symptoms, and both the Hypersensitivity/Anaphylaxis and Cytokine Release Infusion reaction 
drugs) and total knowledge score.  Another positive correlation was noted between the Cytokine 
Release Infusion reaction drug subscale and Total comfort. See table 6.  
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Table 6: Relationships between knowledge and comfort 
 Basic 
knowledge 
S/S 
hypersensitivity 
subscale 
S/S 
Anaphylaxis 
subscale 
S/S 
CRIR 
subscale 
HAR 
drug 
subscale 
CRIR 
drug 
subscale 
Total 
Knowledge 
Total 
comfort 
Basic knowledge 1 -.412 .398 .155 .196 -.149 .293 .149 
S/S hypersensitivity 
subscale 
 1 .004 -.007 .076 .241 .254 -.101 
S/S Anaphylaxis 
subscale 
  1 .209 .095 -.097 .437 -.091 
S/S CRIR subscale    1 .290 .640** .817** .367 
HAR drug subscale     1 .305 .572** .226 
CRIR drug subscale      1 .721** .548** 
Total Knowledge       1 .403 
Total comfort        1 
Note: ** correlation is significant at the 0.02 level (2 tailed) 
S/S=Signs and Symptoms 
CRIR= Cytokine Release Infusion Reactions 
HAR= Hypersensitivity and Anaphylactic Reactions  
Additional Responses    An additional Likert scale was included in the survey that asked questions about nurses’ 
feelings and beliefs about distress and support. Most notably from this section was the question 
about whether nurses feel a great deal of stress about the possibility that an acute infusion 
reaction could happen at any time. 65% of participants agreed that they feel stressed. However, 
100% of nurses agreed that they felt support from other nurses when encountering an 
anaphylactic reaction, 95% felt support reviewing the events that led to the anaphylactic reaction, 
and 100% felt support educating patients and families about the events that led to the 
anaphylactic reaction. In addition, 10% of nurses did not feel supported in coping with the stress 
related to the experience of dealing with an anaphylactic reaction.  
Qualitative Responses   
 There were two qualitative questions at the end of the survey. When asked what type of 
additional training would be beneficial, responses repeatedly stated that more hands on practice 
would be helpful in a simulation setting. To lower anxiety about reactions, nurses would like to 
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review quick ways to recognize anaphylaxis. Nurses also asked for specific updates on new 
drugs that are being used, specifically biotherapies. They wanted to know what to look for based 
on the drug and what side effects could indicate an infusion reaction.  
 The last question asked the participants if there was anything else they would like to 
share about their experience with acute infusion reactions. The nurses said being prepared with 
the medications that should be given in the event of an anaphylactic reaction is an important step 
to administering any antineoplastic drug. The nurses support each other on the unit in event of 
reactions. Many nurses said that they have not seen many acute infusion reactions since they are 
not very common, and this makes handling the reactions stressful when they do occur. Patient 
load was also a concern. Nurses worried that they might miss signs and symptoms of a reaction 
when they have a busy patient load. Patient observation is key to managing reactions quickly and 
effectively.  
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DISCUSSION 
 
Results from this study indicate that a knowledge deficit related to acute reactions exists.  
Nurses were knowledgeable about approximately 50% of the items. The general knowledge 
questions showed some gaps in knowledge. Some of these knowledge gaps could impact patient 
safety. For example, nurses need to understand that any sign and symptom of a hypersensitivity 
reaction could escalate to anaphylaxis if not treated. The first step to safety is stopping the 
infusion and then checking with the physician on how treatment should proceed. In addition, 
60% of nurses did not believe that a patient would receive the antineoplastic agent again once an 
acute infusion reaction had occurred. The rationale behind this belief makes sense with most 
classes of drugs. If a patient has an allergy to a drug, the nurse knows not to give that medication. 
However, nurses need to realize that many times with antineoplastic drugs there is no other 
alternative to treatment and that patient may indeed receive the drug they reacted to at a later 
date. The nurse should be vigilant in checking the patient’s past history with the drug, because 
past history of an infusion reaction indicates a high risk that it will happen again.  
The last general knowledge question that 60% of nurses missed was the relationship 
between hypersensitivity reactions to things like food or bee strings and the increase likelihood 
of a patient to react to a chemotherapeutic drug. Without being taught about this connection, a 
nurse would not know to ask about hypersensitivity reactions when assessing the patient. This 
simple question could be a clue to the nurse that the patient is more susceptible. 
 In several subscales, Nurses were asked their level of agreement when identifying signs 
and symptoms related to the three types of infusion reactions: hypersensitivity, anaphylaxis, and 
cytokine release infusion reactions. Each subscale had correct and incorrect answers.  It is 
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interesting that for all subscales, nurses tended to agree that most signs/symptoms were an 
indication of a specific reaction. It seems that participants could not discriminate between 
specific signs and symptoms they might see with each type of reaction.  The acquiescence 
response bias did not indicate a total lack of knowledge. The overwhelming choice of agree or 
strongly agree for signs and symptoms in all three infusion reactions suggests an understanding 
that anything unusual when giving an antineoplastic agent could indicate an acute infusion 
reaction.  Assigning a sign or symptom to a particular type of infusion reaction may not be 
important to the scope of practice. What is more important is that the nurse reacts properly to 
anything that indicates a reaction. 
 The large responses of “I don’t know” answers for the subscales asking participants to 
agree with drugs that are most likely to cause an acute infusion reaction may be an indication 
that the nurses do not commonly work with these drugs. Regardless of the nurses’ answers, the 
most important thing a nurse must understand about these drugs is they all possess some level of 
potential to cause an acute infusion reaction. Even if the nurse knows which drugs have a high 
potential to cause an acute infusion reaction and which drugs have a rare potential, the potential 
is present in all drugs. Nurses in the pediatric nurse setting scored lower in selecting drugs that 
cause cytokine release infusion reaction. This many indicate that pediatric nurses do not 
administer these drugs as frequently.   
 The overall comfort score of 37.75 out of 42 possible points for managing acute infusion 
reactions indicates that nurses feel very comfortable in their role of managing acute infusion 
reactions. Nurses feel comfortable assessing for signs and symptoms, educating patients on these 
signs and symptoms, managing the anaphylactic reaction, administering chemo and biotherapy, 
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preparing medication in the event of an acute infusion reaction, and administering the 
medication. This is interesting given the knowledge gaps that were found.  However, this may be 
a positive indication that regardless of knowledge gaps related to basic information about acute 
infusion reactions, nurses feel capable and ready to respond in the event of an infusion reaction.  
There was no relationship between the total knowledge score and total comfort level 
score, but this does not mean that no conclusions can be drawn. A strong foundation in 
knowledge might not be needed to manage an acute infusion reaction. The nurses still possess 
knowledge in how to manage an acute infusion reaction; they just lack specific knowledge 
related to details of the type of infusion reactions and the drugs. Perhaps what is most important 
in training successful and confident nurses is ensuring that they know what to assess and how to 
react when necessary. In a study conducted with nursing students in which the knowledge of 
genetics was tested pre course work and post course work, nurses seemed to be more familiar 
with higher level applications of genetic issues despite being unable to answer the genomic basic 
knowledge subset (Monroe & Loerzel, 2016). This suggests the same concept, that a nurse can 
manage an acute infusion reaction without knowing other basic concepts on the topic. The 
oncology nurses know they need to be prepared to act, so they must recognize any sign or 
symptom and then feel comfortable reacting.  
Correlations show a positive relationship between some knowledge subscales and total 
knowledge score.  This makes sense, because if the knowledge in the subscales was low, it was 
reflected in the total (low) knowledge score.  The correlation between the cytokine release 
infusion reactions drug selection subscale and total comfort is interesting.  More research is 
needed to explore this relationship and determine if it is meaningful. 
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Limitations  
 The limitations of this study include the investigator-developed survey. While two 
experts in the field reviewed this survey and provided face validity, it might not have been 
adequate to capture nurses’ knowledge of management of an acute infusion reaction. Questions 
may have been unclear to participants and may not have adequately captured specific aspects of 
knowledge related to acute infusion reactions. Upon further examination, the survey’s 
knowledge section and comfort level section are asking different concepts about acute infusion 
reactions. The knowledge questions seek to test drug knowledge, signs and symptoms specific to 
infusion reactions, and risk factors. The comfort level questions ask more about management of 
the reaction.  If the knowledge question and comfort level questions were more closely aligned, 
perhaps there would have been a relationship present between the two variables. 
 Another limitation of the survey were the demographic questions: how many infusion 
reactions do you see in a month and year? The use of the word “see” does not verify whether the 
nurses actually took part in managing this reaction.  
 An additional limitation was the sample size. A larger sample size would have produced 
more reliable results. In addition, there was not a lot of variation among demographics. Using a 
sample size of new nurses might have shown a correlation between knowledge scores and 
comfort scores, because clinical experience would not have influenced their comfort subscale.  
Implications for Research   
 A revised survey that connects knowledge style questions to comfort level questions 
would be beneficial to continue this research. Further revision of the survey may focus on 
knowledge of nursing management of acute infusion reactions. A bigger more diverse sample 
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would be more indicative of whether there is a relationship between knowledge score and 
comfort level. A test of how nurses react and manage acute infusion reactions could also measure 
if comfort level matches actual performance. The knowledge Likert scales all scored high in 
internal consistency when Alpha-coefficients were run for reliability except for drugs most likely 
to cause hypersensitivity and anaphylactic reactions. This would need to be examined in a future 
study. 
Implications for Education and Practice  
 The gaps in knowledge that were identified and the needs reported by nurses in the 
qualitative section inform our implications for practice and education. The knowledge gaps 
addressed in the discussion suggest a few points that nurses would benefit reviewing. Some 
nurses still reported feeling a great deal of stress about the potential for an acute infusion reaction 
to happen. In the qualitative responses there were several nurses who wanted more hands on 
training and review of new and most used drugs. Simulation training and in-service training 
could help nurses feel more prepared. Nurses could practice in an environment where mistakes 
were safe to make. Reinforced hands on training quarterly could also decrease stress, because 
one of the largest reasons nurses complained of stress was lack of exposure to these reactions.  
 Posters on the units with the most common drugs that cause acute infusion reactions may 
be helpful to nurses, especially if the signs and symptoms of what to look for are present. Nurse 
huddles could also be a great time to review new drugs that are being used in treatment, since 
some nurses complained of not feeling up-to-date on all of the new drugs being used. This was 
also consistent with their lack of knowledge on the specific drugs. 
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Nursing Knowledge and Comfort Level with Acute Infusion Reactions  Demographic Questions   Q1 Are you currently working as a registered nurse with direct patient care?  
 Yes  
 No   Q2 What is your age?   Q3 What is the highest educational degree that you have received?  
 Nursing Diploma  
 Associate of Science  
 Bachelor's Degree  
 Master's Degree  
 Doctoral Degree   Q4 How many years have you practiced as a registered nurse?    Q5 How many years have you worked with the oncology patient population?   Q6 Are you a member of a professional oncology nurse organization? 
 Association of Pediatric Hematology/ Oncology Nursing (APHON)  
 Oncology Nursing Society (ONS) 
 Other ____________________  Q7 How many years have you administered antineoplastic drugs (e.g: chemotherapy) to patients?   Q8 What certifications or trainings have you completed relating to oncology nursing?  
 Oncology Certified Nurse (OCN)  
 Certified Pediatric Hematology/Oncology Nurse (CPHON)  
 Certified Pediatric Oncology Nurse (CPON)  
 ONS Chemotherapy & Biotherapy Course  
 APHON Chemotherapy & Biotherapy Course  
 Orlando Health Chemotherapy Verification Course  
 Other  ____________________  
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Q9 What is your current work setting?  
 Inpatient  
 Outpatient   Q10 What is your primary patient population?   
 Adult 
 Pediatric  
  Q11 How many acute infusion reactions caused by antineoplastic drugs do you see in a month?  
 0  
 1-2  
 3-4  
 5-6  
 7-8  
 9-10  
 10+   Q12 How many acute infusion reactions caused by  antineoplastic drugs do you see in a year?  
 0  
 1-2  
 3-4  
 5-6  
 7-8  
 9-10  
 10+   Please answer the following questions about acute infusion reactions caused by antineoplastic agents.    Q13 What is the probability of a patient having a severe infusion reaction to antineoplastic agents?   
 5%  
 10%  
 25%  
 50%  
 90%   
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Q14 Select the statement that best describes a hypersensitivity reaction.  
 A severe life-threatening allergic reaction.  
 Allergic reaction triggered by a drug, diluent, or solution.  
 An immune response to a monoclonal agent.   Q15 Select the statement that best describes an anaphylactic reaction.   
 A severe life-threatening allergic reaction.  
 Allergic reaction triggered by a drug, diluent, or solution.  
 An immune response to a monoclonal agent.   Q16 Select the statement that best describes a cytokine release infusion reaction.  
 A severe life-threatening allergic reaction. 
 Allergic reaction triggered by a drug, diluent, or solution.  
 An immune response to a monoclonal agent.   Please answer the following questions about acute infusion reactions.  Q17 Cumulative doses of asparaginase increases the likelihood that a hypersensitivity reaction will occur.  
 True  
 False   Q18 Hypersensitivity reactions are more common when the antineoplastic agent is administered intermittently versus daily.  
 True  
 False   Q19 A patient is more likely to have a hypersensitivity reaction to antineoplastic agent on the first dose than with subsequent doses. 
 True  
 False   Q20 A patient is more likely to have an infusion reaction to biotherapy on the first dose than with subsequent doses.  
 True  
 False   
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Q21 Hypersensitivity reactions are more common when chemotherapy is administered parenterally versus intramuscularly.  
 True  
 False   Q22 As long as signs and symptoms of hypersensitivity are mild the chemotherapy infusion may be continued.  
 True  
 False   Q23 The chance of a patient receiving an antineoplastic drug once he/she has had an anaphylactic reaction is highly unlikely.    
 True  
 False   Q24 Hypersensitivity reactions can occur up to two weeks after chemotherapy is administered.  
 True  
 False   Q25 Rapid infusion of a chemotherapeutic drug is more likely to prevent hypersensitivity reactions.  
 True  
 False   Q26 A patient with a history of hypersensitivity reactions to something like food or bee strings is more likely to react to a chemotherapeutic drug.    
 True  
 False   Q27 You only need to observe the patient for signs and symptoms of a hypersensitivity reaction for 15 minutes. 
 True  
 False   Q28 Epinephrine should be administered by IV Push in the case of an anaphylactic reaction.   
 True  
 False   
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Q29 At the first sign of a hypersensitivity reaction, the most common medications prescribed and administered are: (Select all that apply.)    
 Acetaminophen (Tylenol)  
 Diphenhydramine (Benadryl)  
 Hydrocortisone (SoluCortef)  
 Meperidine (Demerol)   Q30 Which of the following signs and symptoms are most commonly associated with hypersensitivity reactions?   Strongly Disagree (1) Disagree (2) I don't know (3) Agree (4) Strongly Agree (5) Angioedema            Pruritus            Nausea and Vomiting            Laryngeal Edema           Fever or Chills            Hypotension            Dyspnea            Watery Nose            Feelings of Impending Doom            Tongue and Throat Swelling            Wheezing            Asthenia            Tachycardia            Bronchospasm            Chest Tightness                
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Q31 Which of the following signs and symptoms are most commonly associated with anaphylactic reactions?   Strongly Disagree (1) Disagree (2) I don't know (3) Agree (4) Strongly agree (5) Angioedema            Pruritus            Nausea and Vomiting            Laryngeal Edema           Fever or Chills            Hypotension            Dyspnea            Watery Nose            Feelings of Impending Doom            Tongue and Throat Swelling            Wheezing            Asthenia            Tachycardia            Bronchospasm            Chest Tightness                 
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Q32 Which of the following signs and symptoms are most commonly associated with cytokine release infusion reactions?   Strongly Disagree (1) Disagree (2) I don't know (3) Agree (4) Strongly agree (5) Angioedema            Pruritus            Nausea and Vomiting            Laryngeal Edema            Fever or Chills            Hypotension            Dyspnea            Watery Nose            Feelings of Impending Doom            Tongue and Throat Swelling            Wheezing            Asthenia            Tachycardia            Bronchospasm            Chest Tightness                 
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Q33 Which of the following chemotherapeutic drugs have a high potential for causing hypersensitivity and/or anaphylactic reactions?  Strongly Disagree (1) Disagree (2) I don't know (3) Agree (4) Strongly agree (5) Procarbazine             Methotrexate             Docetaxel             Taxanes             Hydroxyurea             Dacarbazine             Asparaginase             Cisplatin             Etoposide             Bleomycin             Carboplatin               
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Q34 Which of the following chemotherapy and/or biotherapy drugs have a high potential for causing a cytokine release infusion reaction?  Strongly Disagree (1) Disagree (2) I don't know (3) Agree (4) Strongly agree (5) Interferons             Interleukins             Rituximab             Cetuximab             Bortezomib             Azacitidine             Alemtuzumab             Bevacizumab             Gemtuzumab             Trastuzumab             Panitumumab                 
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  Extremely uncomfortable (1) Moderately uncomfortable (2) Slightly uncomfortable (3) Slightly comfortable (4) Moderately comfortable (5) Extremely comfortable (6) Assessing for signs and symptoms of acute infusion reactions   
            
Educating patients and families on the signs and symptoms of acute infusion reactions   
            
Educating patients and families on the antineoplastic drug prescribed to the patient   
            
Managing an anaphylactic reaction               Administering chemotherapy and biotherapy               Preparing medications to administer in the event of an acute infusion reactions   
            
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Administering supportive medications in the event of an acute infusion reactions   
            
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 Strongly disagree (1) Disagree (2) Somewhat disagree (3) Somewhat agree (4) Agree (5) Strongly agree (6) I am able to remain calm and react quickly in the presence of a severe acute infusion reaction.   
            
I feel a great deal of stress about the potential for an anaphylactic reaction to occur in one of my patients.   
            
I believe there is a potential for my patient to have an anaphylactic reaction at any time.   
            
After encountering an anaphylactic reaction, I felt I acted appropriately and confidently.   
            
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If I encounter an anaphylactic reaction in the future, I believe I will act appropriately and confidently.   
            
I have support from other nurses when encountering an anaphylactic reaction.   
            
I have support reviewing event that led to an anaphylactic reaction.   
            
I have support educating patients and families about the events that led to an anaphylactic reaction.   
            
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I have support in coping with the stress related to the experience of dealing with an anaphylactic reaction.   
            
  The last two questions are opening ended responses. Please include anything else you feel may be pertinent to this survey or anything else you would like to share.   Q37 What type of further training would be beneficial to you with hypersensitivity reactions from antineoplastic agents?   Q38 What else would you like to include about your experience with hypersensitivity reactions in the oncology setting?  
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